Boehringer Ingelheim Drug Wins FDA Approval for Treating Fatal Lung Disorder IPF

Boehringer Ingelheim’s Jascayd blocks a protein involved in the lung inflammation that develops from idiopathic pulmonary fibrosis, a rare and ultimately fatal disease with few available therapies. The twice-daily pill doesn’t cure IPF but clinical trial results showed it slowed disease progression. The post Boehringer Ingelheim Drug Wins FDA Approval for Treating Fatal Lung Disorder…

Read More

The Healthcare Sector’s Digital Contagion: Ransomware’s Relentless Grip

In a sector where delays are measured in lives, early detection, lower attacker dwell time, and system-level misdirection can literally save lives. By marrying preemptive and deceptive technologies, organizations can blunt the attack surface while simultaneously exposing hidden threats before damage is done.  The post The Healthcare Sector’s Digital Contagion: Ransomware’s Relentless Grip appeared first…

Read More

Donor Government Funding for Family Planning Reports

These reports track funding levels of the donor governments that collectively provide the bulk of international assistance for family planning activities and is part of an effort by KFF that began after the London Summit on Family Planning in 2012. It presents their bilateral assistance to low- and middle-income countries as well as contributions to…

Read More